Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511) WILL HOLD ITS ANNUAL GENERAL MEETING VIA VIRTUAL CONFERENCE ON MAY 16, 2024. The meetings will include resolutions to approve the 2023 audited financial statements and Board reports, re-elect directors, determine directors' remuneration, renew auditors, and authorize the Board to distribute and repurchase shares. Shareholders shall appoint representatives to attend the General Meeting and vote as directed or, without indication, by the representatives at their discretion. Shareholders are required to submit the Proxy Form 48 hours prior to the appointed time of the General Meeting.